Research Article
The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure
Table 6
Parameters influencing outcome.
| | Univariate Cox regression analysis | HR | 95% CI for HR | p |
| | NYHA (class IV versus I–III) | 3.48 | 1.452–8.359 | 0.005 | | APN (μg/ml) | 1.04 | 1.016–1.067 | 0.001 | | IL-6 (pg/ml) | 1.04 | 1.01–1.07 | 0.004 | | BNP (pg/ml) | 1.00 | 1.000–1.000 | 0.061 | | Average global strain (%) | 1.69 | 1.322–2.180 | <0.001 | | CD3+ (cells/mm2) | 1.06 | 1.015–1.099 | 0.006 | | LVEF (%) | 0.93 | 0.882–0.983 | 0.010 | | Mean PAP (mmHg) | 1.06 | 1.018–1.097 | 0.004 | | Mean PCWP (mmHg) | 1.07 | 1.022–1.127 | 0.004 |
|
|
APN: adiponectin, IL-6: interleukin-6, BNP: brain natriuretic peptide, CD3+: T cell receptor, LVEF: left ventricle ejection fraction, PAP: pulmonary artery pressure, and PCWP: pulmonary capillary wedge pressure.
|
